Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy

References

• BresslerNMAge related macular degeneration is the leading cause of blindnessJAMA2004291151900190115108691
   PubMedGoogle Scholar
• AveryRLFekratSHawkinsBSBresslerNMNatural history of subfoveal subretinal hemorrhage in age-related macular degenerationRetina19961631831898789855
   PubMed Web of Science ®Google Scholar
• BennetSFolkJBlodiCKlugmanMFactors prognostic of visual outcome in patients with subretinal hemorrhageAm J Ophthalmol1990109133372297030
   PubMed Web of Science ®Google Scholar
• BresslerNMBresslerSBChildsALSurgery for hemorrhagic choroidal neovasular lesions of age-related macular degeneration: ophthalmic findings: SST report no 13Ophthalmology2004111111993200615522364
   PubMed Web of Science ®Google Scholar
• MattGSacuSStifterEPrünteCSchmidt-ErfurthUCombination of intravitreal rTPA, gas and ranibizumab for extensive subfoveal hemorrhages secondary to neovascular age-related macular degenerationKlin Monbl Augenheilkd20102273221225 German20234987
   PubMed Web of Science ®Google Scholar
• HaupertCLMcCuenBWJaffeGJPars plana vitrectomy, sub-retinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degenerationAm J Ophthalmol2001131220821511228297
   PubMed Web of Science ®Google Scholar
• HillenkampJSurguchVFrammeCGabelVPSachsHGManagement of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activatorGraefes Arch Clin Exp Ophthalmol2010248151119669780
   PubMed Web of Science ®Google Scholar
• AriasLMonésJTransconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age related macular degenerationClin Ophthalmol20104677220186279
   PubMedGoogle Scholar
• MeyerCHSchollHPEterNHelbHMHolzFGCombined treatment of acute subretinal hemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot studyActa Ophthalmol200886549049418221499
   PubMed Web of Science ®Google Scholar
• TreumerFRoiderJHillenkampJLong-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovasular AMD with submacular hemorrhageBr J Ophthalmol201296570871322174095
   PubMed Web of Science ®Google Scholar
• SacuSStifterEVécsei-MarlovitsPVManagement of extensive subfoveal hemorrhage secondary to neovascular age-related macular degenerationEye (Lond)20092361404141018756282
   PubMed Web of Science ®Google Scholar
• BrownDMKaiserPKMichelsMANCHOR study groupRanibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med2006355141432144417021319
   PubMed Web of Science ®Google Scholar
• RosenfeldPJBrownDMHeierJSMARINA study groupRanibizumab for neovascular age-related macular degenerationN Engl J Med2006355141419143117021318
   PubMed Web of Science ®Google Scholar
• CATT Research GroupMartinDFMaguireMGRanibizumab and bevacizumab for neovasular age-related macular degenerationN Engl J Med201119;3642018971908
   Web of Science ®Google Scholar
• StifterEMichelsSPragerFIntravitreal bevacizumab therapy for neovasular age-related macular degeneration with large submacular hemorrhageAm J Ophthalmol2007144688689217916314
   PubMed Web of Science ®Google Scholar
• ShienbaumGGarcia FilhoCAFlynnHWJrNunesRPSmiddyWERosenfeldPJManagement of submacular hemorrhage secondary to neo-vasular age-related macular degeneration with anti-Vascular endothelial growth factor monotherapyAm J Ophthalmol201315561009101323465269
   PubMed Web of Science ®Google Scholar
• ChangMADoDVBresslerSBCassardSDGowerEWBresslerNMProspective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degenerationRetina20103081171117620827138
   PubMed Web of Science ®Google Scholar
• IaconoPParodiMBIntroiniULa SpinaCVaranoMBandelloFIntravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degenerationRetina201434228128723851632
   PubMed Web of Science ®Google Scholar
• KimJHChangYSKimJWKimCGYooSJChoHJIntravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularizationOphthalmology2014121492693524342019
   PubMed Web of Science ®Google Scholar
• McKibbinMPapastefanouVMatthewsBCookHDowneyLRanibizumab monotherapy for sub-foveal hemorrhage secondary to choroidal neovascularisation in age-related macular degenerationEye (Lond)201024699499819911016
   PubMed Web of Science ®Google Scholar
• AltaweelMMDanielEMartinDFOutcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)Ophthalmology2015122239139825307130
   PubMed Web of Science ®Google Scholar
• YingGSHuangJMaguireMGBaseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degenerationOphthalmology2013120112212923047002
   PubMed Web of Science ®Google Scholar
• ChoHJKohKMKimJHIntravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degenerationRetina201535220521225105310
   PubMed Web of Science ®Google Scholar
• ChangWGargSJMaturiRManagement of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degenerationAm J Ophthalmol201415761250125724531021
   PubMed Web of Science ®Google Scholar
• ScupolaACoscasGSoubraneGBalestrazziENatural history of macular subretinal hemorrhage in age-related macular degenerationOphthalmologica19992132971029885385
   PubMed Web of Science ®Google Scholar
• KauffmannYIsaicoRLefebvreABronAMCreuzot-GarcherCRelationship between intravitreal anti-VEGF therapy and subretinal hemorrhage in patients with exudative age-related macular degenerationJ Fr Ophtalmol2014373195201 French24534623
   PubMed Web of Science ®Google Scholar